Positive Health Online
Your Country
Research: SHAH and COLLEAGUES,
Listed in Issue 193
Abstract
SHAH and COLLEAGUES, Department of Pediatric Surgery, University of Texas Medical School at Houston, Houston, Texas 77030, USA review the published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) in cancer patient trials.
Background
The purpose of this review is to present the currently published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) as complementary therapy in patients with cancer.
Methodology
The authors explore the current preclinical and clinical evidence as it relates to this topic and its potential use in the surgical oncology patient.
Results
There has been a growing interest in stimulation of the immune system in trauma, cancer, and surgical patients in general. Little, however, has been written about some-of the supplements in widely used in Japan and China, but relatively unheard of in the United States.
Conclusion
References
Shah SK, Walker PA, Moore-Olufemi SD, Sundaresan A, Kulkarni AD and Andrassy RJ. An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient. [Review] Jpen: Journal of Parenteral & Enteral Nutrition. 35(4): 449-58. Jul 2011.